Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands.

Vencken, P M L H; Reitsma, W; Kriege, M; Mourits, M J E; de Bock, G H; de Hullu, J A; van Altena, A M; Gaarenstroom, K N; Vasen, H F A; Adank, M A; Schmidt, M K; van Beurden, M; Zweemer, R P; Rijcken, F; Slangen, B F M; Burger, C W; Seynaeve, C

Vencken, P M L H; Reitsma, W; Kriege, M; Mourits, M J E; de Bock, G H; de Hullu, J A; van Altena, A M; Gaarenstroom, K N; Vasen, H F A; Adank, M A; Schmidt, M K; van Beurden, M; Zweemer, R P; Rijcken, F; Slangen, B F M; Burger, C W; Seynaeve, C.

Affiliation

Vencken PM; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Erasmus University Medical Center, Rotterdam, The Netherlands.

Ann Oncol ; 24(8): 2036-42, 2013 Aug.

Article in En | MEDLINE | ID: mdl-23543211

Subject(s)

BRCA1 Protein/genetics; BRCA2 Protein/genetics; Neoplasms, Glandular and Epithelial/genetics; Neoplasms, Glandular and Epithelial/mortality; Ovarian Neoplasms/genetics; Ovarian Neoplasms/mortality; Adult; Aged; Antineoplastic Agents, Phytogenic/therapeutic use; Carcinoma, Ovarian Epithelial; Disease-Free Survival; Female; Humans; Middle Aged; Neoplasms, Glandular and Epithelial/drug therapy; Neoplasms, Glandular and Epithelial/surgery; Netherlands; Ovarian Neoplasms/drug therapy; Ovarian Neoplasms/surgery; Paclitaxel/therapeutic use; Platinum Compounds/therapeutic use; Survival; Treatment Outcome

Key words

BRCA1; BRCA2; chemotherapy; ovarian cancer; response; survival

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplasms, Glandular and Epithelial / BRCA1 Protein / BRCA2 Protein Type of study: Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Journal: Ann Oncol Year: 2013 Document type: Article

Fulltext

XML

PubMed Links

Search on Google